The use of gadolinium-BOPTA on magnetic resonance imaging in brain infection

Investigative Radiology

Volumn 31, Issue 5, 1996, Pages 294-299

  Runge, Val M ^a   Wells, John W ^a   Williams, Neil M ^a   Timoney, John F ^a   Lee, Charles ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

brain; contrast enhancement; infection; Magnetic resonance

Indexed keywords

GADOBENIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ABSCESS; BRAIN INFECTION; CHEMICAL STRUCTURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 0029872163     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199605000-00009     Document Type: Article

References (20)

1. Bradley WG, Yuh WTC, Bydder GM. Use of MR imaging contrast agents in the brain. J Magn Reson Imaging 1993;3:199-218.
2. Vogl TJ, Pegios W, McMahon C, et al. Gadobenate dimeglumine - a new contrast agent for MR imaging: Preliminary evaluation in healthy volunteers. AJR Am J Roentgenol 1992;158: 887-892.
3. Runge VM, Wells JW, Kirsch JE. Magnetization transfer and high dose contrast in early brain infection on MR. Invest Radiol 1995;30:135-143.
4. Hajnal JV, Baudouin CJ, Oatridge A, et al. Design and implementation of magnetization transfer pulse sequences for clinical use. J Comput Assist Tomogr 1992;16:7-18.
5. Wolff SD, Eng J, Balaban RS. Magnetization transfer contrast: Method for improving contrast in gradient-recalled-echo images. Radiology 1991;179:133-137.
6. Ordidge RJ, Knight RA, Helpern JA. Magnetization transfer contrast (MTC) in FLASH MR imaging. Magn Reson Imaging 1991;9:889-893.
7. Sze G, Milano E, Johnson C, Heier L. Detection of brain metastases: Comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. AJNR 1990;11:785-791.
8. Virapongse C, Mancuso A, Quisling R. Human brain infarcts: Gd DTPA enhanced MR imaging. Radiology 1986;161:785-794.
9. Cavagna FM, Maggioni F, Castelli PM, et al. Contrast enhanced magnetization transfer MRI of rat brain tumors with Gd BOPTA/dimeg and Gd DTPA/dimeg. Presented at the third Society of Magnetic Resonance meeting; August 1995; Nice, France.
10. Maggioni F, Castelli PM, Marzola P, et al. Magnetization transfer MR imaging of experimental rat brain tumors with Gd BOPTA/dimeglumine and Gd DTPA/dimeglumine. Radiology 1995;197(P):149.
11. Britt RH, Enzmann DR, Yeager AS. Neuropathological and computerized tomographic findings in experimental brain abscess. J Neurosurg 1981;55:590-603.
12. Mirowitz SA, Lee JKT, Gutierrez E, et al. Dynamic gadolinium enhanced rapid acquisition spin echo MR imaging of the liver. Radiology 1991;179:371-376.
13. Stark DD, Weissleder R, Elizondo G, et al. Superparamagnetic iron oxide: Clinical application as a contrast agent for MR imaging of the liver. Radiology 1988;168:297-301.
14. Schuhmann-Giampieri G. Liver contrast media for magnetic resonance imaging. Interrelations between pharmacokinetics and imaging. Invest Radiol 1993;28:753-761.
15. Saeed M, Wendland MF, Sakuma H, et al. Coronary artery stenosis: Detection with contrast-enhanced MR imaging in dogs. Radiology 1995;196:79-84.
16. Cavagna FM, Marzola P, Dapra M, et al. Binding of gadobenate dimeglumine to proteins extravasated into interstitial space enhances conspicuity of reperfused infarcts. Invest Radiol 1994;29(suppl 2):S50-S53.
17. Saeed M, Wendland MF, Yu KK, et al. Identification of myocardial reperfusion with echo planar magnetic resonance imaging: Discrimination between occlusive and reperfused infarctions. Circulation 1994;90:1492-1501.
18. Kreft BP, Tanimoto A, Baba Y, et al. Enhanced tumor detection in the presence of fatty liver disease: Cell-specific contrast agents. J Magn Reson Imaging 1994;4:337-342.
19. Kreft BP, Tanimoto A, Stark DD, et al. Enhancement of tumor-liver contrast-to-noise ratio with gadobenate dimeglumine in MR imaging of rats. J Magn Reson Imaging 1993;3:41-49.
20. Rosati G, Pirovano G, Spinazzi A. Interim results of phase II clinical testing of gadobenate dimeglumine. Invest Radiol 1994;29(suppl 2):S183-S185.